Inhibitory mechanism of taurine on the platelet-derived growth factor BB-mediated proliferation in aortic vascular smooth muscle cells

Advances in Experimental Medicine and Biology

Volumn 526, Issue , 2003, Pages 5-15

  Imada, Keisuke ^a   Hosokawa, Yu ^b   Terashima, Masaharu ^c   Mitani, Toshifumi ^c   Tanigawa, Yoshinori ^c   Nakano, Kazumi ^a   Takenaga, Takaaki ^a   Kurachi, Michio ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

^b JISSEN WOMEN'S UNIVERSITY   (Japan)

^c SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; PLATELET DERIVED GROWTH FACTOR BB; TAURINE; PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR BB; PRIMER DNA;

AORTA MEDIA; ARTICLE; ATHEROSCLEROSIS; CATABOLISM; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; AORTA; CELL DIVISION; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; IMMEDIATE EARLY GENE; MALE; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; AORTA; BASE SEQUENCE; CELL DIVISION; CELL LINE; DNA PRIMERS; GENE EXPRESSION REGULATION; GENES, IMMEDIATE-EARLY; MALE; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; TAURINE;

EID: 1542673328     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0077-3_2     Document Type: Article

References (17)

1. Ross, R., 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature 362:801-809.
2. Heldin, C-H. and Westermark, B., 1999, Mechanism of action and in vivo role of platelet-derived growth factor, Physiol. Rev. 79:1283-1316.
3. Huxtable, R.J., 1992, Physiological actions of taurine, Physiol. Rev. 72:101-163.
4. Herrmann, R.G, 1959, Effect of taurine, glycine and β-sitosterols on serum and tissue cholesterol in the rat and rabbit, Circulation Res. 7:224-227.
5. Mann, G.V., 1960, Experimental atherosclerosis: Effects of sulfur compounds on hypercholesteremia and growth in cysteine-deficient monkeys, Am. J. Clin. Nutr. 8:491-498.
6. Yokogoshi, H., Mochizuki, H., Nanami, K., Hida, Y., Miyachi, F. and Oda, H., 1999, Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet, J. Nutr. 129:1705-1712.
7. Takenaga, T., Imada, K. and Otomo, S., 2000, Hypolipidemic effect of taurine in golden Syrian hamsters, Adv. Exp. Med. Biol. 483:187-92.
8. Castelli, W.P., Garrison, R.J.. Wilson, P.W.F., Abbott, R.D., Kalousdian, S. and Kannel, W.B., 1986, Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study, JAMA 256:2835-2838.
9. Austin, M.A., 1991, Plasma triglyceride and coronary heart disease, Arterioscler. Thromb. 11:2-14.
10. Petty, M.A., Kintz, J. and DiFrancesco, G.F., 1990, The effect of taurine on atherosclerosis development in cholesterol-fed rabbits, Eur.J.Pharmacol. 180:119-127.
11. Murakami, S., Kondo, Y., Sakurai, T., Kitajima, H. and Nagate, T., 2002, Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits, therosclerosis 163:79-87.
12. Imada, K., Takenaga, T., Otomo, S., Hosokawa, Y. and Totani, M., 2000, Taurine attenuates the induction of immediate-early gene expression by PDGF-BB, Adv. Exp. Med. Biol. 483:589-594.
13. Thommes, K.B., Hoppe, J., Vetter, H. and Sachinidis, A., 1996, The synergistic effect of PDGF-AA and IGF-1 on VSMC proliferation might be explained by the differential activation of their intracellular signaling pathways. Exp. Cell. Res. 226:59-66.
14. Chomczynski, P. and Sacchi, N., 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162:156-159.
15. Firulli, A.B., Han, D., Kelly-Roloff, L., Koteliansky, V.E., Schwartz, S.M., Olson, E.N. and Miano, J.M., 1998, A comparative molecular analysis of four rat smooth muscle cell lines, In Vitro Cell Dev. Biol. Anim. 34:217-226.
16. Kanayama, A., Inoue, J., Sugita-Konishi, Y., Shimizu, M. and Miyamoto, Y., 2002, Oxidation of I-kappa B alpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation. J. Biol. Chem. 277:24049-24056.
17. Takahashi, K., Azuma, M., Taira, K., Baba, A., Yamamoto, I., Schaffer, S.W. and Azuma, J., 1997, Effect of taurine on angiotensin II-induced hypertrophy of neonatal rat cardiac cells. J. Cardiovasc. Pharmacol. 30:725-730.